Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-011846
Filing Date
2026-01-13
Accepted
2026-01-13 16:47:48
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B5 d59284d424b5.htm 424B5 55812
2 EX-FILING FEES d59284dexfilingfees.htm   iXBRL EX-FILING FEES 21008
3 GRAPHIC g59284g00n01.jpg GRAPHIC 67871
  Complete submission text file 0001193125-26-011846.txt   285425

Data Files

Seq Description Document Type Size
15 EXTRACTED XBRL INSTANCE DOCUMENT d59284dexfilingfees_htm.xml XML 6286
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286230 | Film No.: 26530628
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)